Purpose: Patients with early-onset breast and/or ovarian cancer frequently wish to know if they inherited a mutation in one of the cancer susceptibility genes, BRCA1 or BRCA2. Accurate carrier prediction models are needed to target costly testing. Two widely used models, BRCAPRO and BOADICEA, were developed using data from non-Hispanic Whites (NHW), but their accuracies have not been evaluated in other racial/ ethnic populations. Methods: We evaluated the BRCAPRO and BOADI-CEA models in a population-based series of African American, Hispanic, and NHW breast cancer patients tested for BRCA1 and BRCA2 mutations. We assessed model calibration by evaluating observed versus predicted mutations and attribute diagrams, and model discrimination usi...
Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or B...
Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or B...
OBJECTIVE: To evaluate the predictive efficacies including sensitivity and positive predictive value...
To establish whether existing mutation prediction models can identify which male breast cancer (MBC)...
Objectives: Genetic testing for the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 h...
PURPOSE: To evaluate in current practice the performance of BOADICEA and BRCAPRO risk models and ...
Background: BRCA1/2 mutation prediction models (BRCAPRO, Myriad II, Couch, Shattuck-Eidens, BOADICEA...
Objectives: To evaluate the accuracy of algorithms for predicting BRCAI/2 germ-line mutation carrier...
The Author(s) 2011. This article is published with open access at Springerlink.com Abstract Many stu...
Approximately 12 % of the U.S. population is Hispanic, with the majority residing in urban centers s...
Inherited mutations of the BRCA1/2 genes confer a significantly increased risk for breast and/or ova...
Introduction: Mutations in BRCA1 and BRCA2 confer high risks of breast cancer and ovarian cancer. Th...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
BACKGROUND: Breast cancer is an extremely complex disease, characterized by a progressive multist...
INTRODUCTION: Mutations in BRCA1 and BRCA2 confer high risks of breast cancer and ovarian cancer. Th...
Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or B...
Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or B...
OBJECTIVE: To evaluate the predictive efficacies including sensitivity and positive predictive value...
To establish whether existing mutation prediction models can identify which male breast cancer (MBC)...
Objectives: Genetic testing for the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 h...
PURPOSE: To evaluate in current practice the performance of BOADICEA and BRCAPRO risk models and ...
Background: BRCA1/2 mutation prediction models (BRCAPRO, Myriad II, Couch, Shattuck-Eidens, BOADICEA...
Objectives: To evaluate the accuracy of algorithms for predicting BRCAI/2 germ-line mutation carrier...
The Author(s) 2011. This article is published with open access at Springerlink.com Abstract Many stu...
Approximately 12 % of the U.S. population is Hispanic, with the majority residing in urban centers s...
Inherited mutations of the BRCA1/2 genes confer a significantly increased risk for breast and/or ova...
Introduction: Mutations in BRCA1 and BRCA2 confer high risks of breast cancer and ovarian cancer. Th...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
BACKGROUND: Breast cancer is an extremely complex disease, characterized by a progressive multist...
INTRODUCTION: Mutations in BRCA1 and BRCA2 confer high risks of breast cancer and ovarian cancer. Th...
Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or B...
Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or B...
OBJECTIVE: To evaluate the predictive efficacies including sensitivity and positive predictive value...